Literature DB >> 22411021

Adherence to glaucoma medication: the effect of interventions and association with personality type.

Michele C Lim1, Mitchell R Watnik, Katrina R Imson, Scott M Porter, Alison M Granier.   

Abstract

PURPOSE: To determine whether multiple interventions influence adherence to glaucoma medication and to study the relationship between personality type and adherence.
METHODS: Eighty patients with glaucoma using prostaglandin monotherapy were prospectively randomized to an intervention or a nonintervention group. Over a 5-month period, the intervention group received monthly automated telephone calls reminding them to take their glaucoma medications. At month 3, the intervention group had an office visit with their physician and received education regarding their disease and treatment. The nonintervention group returned at the end of the study period. Adherence was directly measured with an electronic monitoring cap. Outcome measures were adherence rate and therapeutic coverage. Patients completed the Minnesota Multiphasic Personality Inventory-2.
RESULTS: Thirty-eight patients were randomized to the intervention group and 42 were randomized to the nonintervention group. Mean adherence rate for the intervention group over 5 months was 76% and for the nonintervention group, 81%. For the intervention group, adherence did not change significantly after the midstudy visit (P=0.233). No difference existed between the intervention and nonintervention groups before (P=0.456) or after (P=0.134) the midstudy intervention visit. The Minnesota Multiphasic Personality Inventory-2 personality scales for depression (P=0.01) and hypochondriasis (P>0.0001) were significantly associated with poorer adherence.
CONCLUSIONS: Monthly automated telephone reminders, a 1-time educational session, and increased contact with a physician did not improve adherence rate with glaucoma medications. Depression and hypochondriasis personality types were related to poor adherence and highlight the role of psychosocial factors in medication adherence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22411021     DOI: 10.1097/IJG.0b013e31824cd0ae

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  11 in total

1.  The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study.

Authors:  Paula Anne Newman-Casey; Leslie M Niziol; Brenda W Gillespie; Nancy K Janz; Paul R Lichter; David C Musch
Journal:  Ophthalmology       Date:  2020-01-10       Impact factor: 12.079

2.  Overcoming Barriers to Eye Care: Patient Response to a Medical Social Worker in a Glaucoma Service.

Authors:  Scott J Fudemberg; Dilru C Amarasekera; Marlee H Silverstein; Kathryn M Linder; Paul Heffner; Lisa A Hark; Michael Waisbourd
Journal:  J Community Health       Date:  2016-08

3.  Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015.

Authors:  Paula Anne Newman-Casey; Megan Dayno; Alan L Robin
Journal:  Expert Rev Ophthalmol       Date:  2016-01-22

4.  Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study.

Authors:  Cecilia N Hollenhorst; Vanessa Elliott; Michele Heisler; Kevin Schneider; Ken Resnicow; Paula Anne Newman-Casey
Journal:  Ophthalmol Glaucoma       Date:  2020-05-07

5.  Trends in and Predictors of Depression Among Participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS).

Authors:  David C Musch; Leslie M Niziol; Nancy K Janz; Brenda W Gillespie
Journal:  Am J Ophthalmol       Date:  2018-09-21       Impact factor: 5.258

6.  Impact of COVID-19 on follow-up and medication adherence in patients with glaucoma in a tertiary eye care centre in south India.

Authors:  G N Subathra; Sharmila R Rajendrababu; Vijayalakshmi A Senthilkumar; Iswarya Mani; B Udayakumar
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

7.  Facilitators and Barriers to Glaucoma Screening Identified by Key Stakeholders in Underserved Communities: A Community-engaged Research Approach.

Authors:  Dena Ballouz; Juno Cho; Maria A Woodward; Angela R Elam; David C Musch; Jason Zhang; Sayoko E Moroi; Leroy Johnson; Jean Cederna; Paula A Newman-Casey
Journal:  J Glaucoma       Date:  2021-05-01       Impact factor: 2.290

8.  Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial.

Authors:  Marcel Bilger; Tina T Wong; Jia Yi Lee; Kaye L Howard; Filipinas G Bundoc; Ecosse L Lamoureux; Eric A Finkelstein
Journal:  Appl Health Econ Health Policy       Date:  2019-12       Impact factor: 2.561

9.  Finding the best glaucoma questionnaire: a qualitative and quantitative evaluation of glaucoma knowledge assessments.

Authors:  Jullia A Rosdahl; Kelly W Muir
Journal:  Clin Ophthalmol       Date:  2015-09-29

10.  Factors contributing to nonadherence to follow-up appointments in a resident glaucoma clinic versus primary eye care clinic.

Authors:  Scott J Fudemberg; Brian Lee; Michael Waisbourd; Rachel A Murphy; Yang Dai; Benjamin E Leiby; Lisa A Hark
Journal:  Patient Prefer Adherence       Date:  2016-01-08       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.